Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Shuai Xia and Xinling Wang.
Shuai Xia
Connection Strength
1.287
Xinling Wang
  1. Pan-coronavirus fusion inhibitors as the hope for today and tomorrow. Protein Cell. 2021 02; 12(2):84-88.
    View in: PubMed
    Score: 0.231
  2. Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol. 2020 08; 17(8):894.
    View in: PubMed
    Score: 0.224
  3. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin. Signal Transduct Target Ther. 2020 06 12; 5(1):92.
    View in: PubMed
    Score: 0.222
  4. Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases. Int J Mol Sci. 2020 May 28; 21(11).
    View in: PubMed
    Score: 0.221
  5. RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol Immunol. 2020 04 07.
    View in: PubMed
    Score: 0.219
  6. Supercoiling Structure-Based Design of a Trimeric Coiled-Coil Peptide with High Potency against HIV-1 and Human ß-Coronavirus Infection. J Med Chem. 2022 02 24; 65(4):2809-2819.
    View in: PubMed
    Score: 0.059
  7. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target Ther. 2020 11 27; 5(1):282.
    View in: PubMed
    Score: 0.057
  8. Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection. Virol Sin. 2020 06; 35(3):340-343.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.